Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/12/2012US20120178772 Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
07/12/2012US20120178771 Oral Pharmaceutical Compositions of Buprenorphine and Method of Use
07/12/2012US20120178770 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
07/12/2012US20120178769 Novel compounds for inhibiting eef-2 kinase activity
07/12/2012US20120178768 Phosphodiesterase inhibitor treatment
07/12/2012US20120178767 Treatment of liver disorders with p13k inhibitors
07/12/2012US20120178766 Furopyrimidinedione derivatives as trpai modulators
07/12/2012US20120178765 Novel glucokinase activators and processes for the preparation thereof
07/12/2012US20120178764 Novel Compounds
07/12/2012US20120178763 Method of Treating Anxious Major Depressive Disorder
07/12/2012US20120178762 Compositions of azimilide dihydrochloride
07/12/2012US20120178761 Pyrrolidine derivatives
07/12/2012US20120178760 Heterocyclic-Fused Pyrazolo[4,3-c] Pyridin-3-One M1 Receptor Positive Allosteric Modulators
07/12/2012US20120178759 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
07/12/2012US20120178758 Styryl-triazine derivatives and their therapeutical applications
07/12/2012US20120178757 Method For The Prevention Of Cancer Metastasis
07/12/2012US20120178756 Compounds useful as inhibitors of atr kinase
07/12/2012US20120178755 Cyanoisoquinoline compounds and methods of use thereof
07/12/2012US20120178754 Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents
07/12/2012US20120178753 Inhibitors of bruton's tyrosine kinase
07/12/2012US20120178752 Rho kinase inhibitors
07/12/2012US20120178751 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
07/12/2012US20120178750 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
07/12/2012US20120178749 Ns1 protein inhibitors
07/12/2012US20120178748 Heteroaryl compounds and methods of use thereof
07/12/2012US20120178747 Compositions and methods for bone formation and remodeling
07/12/2012US20120178746 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
07/12/2012US20120178745 Novel Crystalline Oxazine Derivative
07/12/2012US20120178744 FUSED TRICYCLIC COMPOUNDS AS NOVEL mTOR INHIBITORS
07/12/2012US20120178743 Novel adenine compound and use thereof
07/12/2012US20120178742 Metabotropic glutamate receptor modulators
07/12/2012US20120178741 Sulfonylamino-Derivatives As Novel Inhibitors Of Histone Deacetylase
07/12/2012US20120178740 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
07/12/2012US20120178739 Lactam compounds useful as protein kinase inhibitors
07/12/2012US20120178738 Dibenzo [b,f] [1,4]oxazapine compounds
07/12/2012US20120178737 Tricyclic Heterocyclic Compounds as Phosphoinositide 3-Kinase Inhibitors
07/12/2012US20120178736 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
07/12/2012US20120178735 2h-chromene compound and derivative thereof
07/12/2012US20120178734 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
07/12/2012US20120178733 Factor xa inhibitors
07/12/2012US20120178732 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease
07/12/2012US20120178731 Nasal, wound and skin formulations and methods for control of antibiotic-resistant staphylococci and other gram-positive bacteria
07/12/2012US20120178730 Sod-imitating metal complexes
07/12/2012US20120178729 Crystalline form i rosuvastatin zinc salt
07/12/2012US20120178728 Use of a copolymer in the form of a solubiliser for a poorly water-soluble compound
07/12/2012US20120178727 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic
07/12/2012US20120178726 Novel compounds
07/12/2012US20120178725 Method of modulating ship activity
07/12/2012US20120178724 Compositions for Reducing the Incidence of Drug Induced Arrhythmia
07/12/2012US20120178723 Heteroaryls and uses thereof
07/12/2012US20120178721 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
07/12/2012US20120178720 Bisphosphonates as Inhibitors of Acid Sphingomyelinase
07/12/2012US20120178719 Modulation of phospholipase d for the treatment of neurodegenerative disorders
07/12/2012US20120178718 Novel imidazolidine compounds as androgen receptor modulators
07/12/2012US20120178717 4-quinolinemethanols as anti-malarial agents
07/12/2012US20120178716 Unsaturated Heterocyclic Derivatives
07/12/2012US20120178715 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
07/12/2012US20120178714 Phosphorus-containing Compounds & Uses Thereof
07/12/2012US20120178713 Phenyl sulphonamides as modulators of ion channels
07/12/2012US20120178712 Phytochemical compositions including sesamin for anti-inflammatory, anti-cytokine storm, and other uses
07/12/2012US20120178711 Cyclodextrin-based polymers for therapeutics delivery
07/12/2012US20120178710 Synthesis of cyclic diguanosine monophosphate and thiophosphate analogs thereof
07/12/2012US20120178709 CRYSTALLINE PHASES OF 5,6-DFICHLORO-2-(ISOPROPYLAMINO)-1-ß-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
07/12/2012US20120178708 Phenethylsulfone isoindoline derivatives and their use
07/12/2012US20120178707 Methods for treating prostrate conditions
07/12/2012US20120178706 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside
07/12/2012US20120178705 Methods for preparation of glycosphingolipids and uses thereof
07/12/2012US20120178704 Prevention and treatment of colon cancer
07/12/2012US20120178699 Klotho protein and related compounds for the treatment and diagnosis of cancer
07/12/2012US20120178697 Compositions and methods for the inhibition of dishevelled proteins
07/12/2012US20120178681 Bipiperidinyl compounds, compositions, containing such compounds and methods of treatment
07/12/2012US20120178680 Glycoside derivatives and uses thereof
07/12/2012US20120178679 Fused aromatic ptp-ib inhibitors
07/12/2012US20120178678 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
07/12/2012US20120178677 Soft protease inhibitors, and pro-soft forms thereof
07/12/2012US20120178674 Mixture of non-digestible oligosaccharides for stimulating the immune system
07/12/2012US20120178672 Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
07/12/2012US20120178671 Inhibition of nfk-b mediated virus replication with specific oligosaccharides
07/12/2012US20120178666 Prodrugs of guanfacine
07/12/2012US20120178629 Apparatus and methods for preparing an emulsion
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177761 Method of making longan seed extract
07/12/2012US20120177756 Synergistic Compositions That Treat or Inhibit Pathological Conditions Associated With Inflammatory Response
07/12/2012US20120177754 Inhibitor of inflammatory conditions
07/12/2012US20120177752 Nutritional compositions including beta-hydroxy-beta-methylbutyrate
07/12/2012US20120177750 Methods for treating pain using topical product formulations containing strontium
07/12/2012US20120177749 Family of pfkfb3 inhibitors with anti-neoplastic activities
07/12/2012US20120177748 Compounds useful as inhibitors of atr kinase
07/12/2012US20120177744 Method of using beta-hydroxy-beta-methylbutyrate for the treatment of cancer
07/12/2012US20120177743 Combinations and modes of administration of therapeutic agents and combination therapy
07/12/2012US20120177742 Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore
07/12/2012US20120177739 Delayed Release Tablet with Defined Core Geometry
07/12/2012US20120177738 Green tea extracts of improved bioavailability
07/12/2012US20120177737 High drug load tablet
07/12/2012US20120177736 Method for treating a patient in need of aspirin therapy
07/12/2012US20120177735 Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
07/12/2012US20120177734 Delayed Release Tablet with Defined Core Geometry
07/12/2012US20120177733 Solid dosage forms of valsartan and amlodipine and method of making the same
07/12/2012US20120177731 Controlled release formulations of levodopa and uses thereof
07/12/2012US20120177730 Chemosensory Receptor Ligand-Based Therapies
1 ... 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 ... 7860